DE602005026310D1 - Verfahren zur herstellung von ibandronat - Google Patents

Verfahren zur herstellung von ibandronat

Info

Publication number
DE602005026310D1
DE602005026310D1 DE602005026310T DE602005026310T DE602005026310D1 DE 602005026310 D1 DE602005026310 D1 DE 602005026310D1 DE 602005026310 T DE602005026310 T DE 602005026310T DE 602005026310 T DE602005026310 T DE 602005026310T DE 602005026310 D1 DE602005026310 D1 DE 602005026310D1
Authority
DE
Germany
Prior art keywords
ibandronate
production
hydroxypropane
monohydrate
pentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005026310T
Other languages
German (de)
English (en)
Inventor
Friedrich Baetz
Bernd Junghans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602005026310D1 publication Critical patent/DE602005026310D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE602005026310T 2004-10-29 2005-10-25 Verfahren zur herstellung von ibandronat Expired - Lifetime DE602005026310D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105407 2004-10-29
PCT/EP2005/011404 WO2006045578A2 (en) 2004-10-29 2005-10-25 Process for the preparation of ibandronate

Publications (1)

Publication Number Publication Date
DE602005026310D1 true DE602005026310D1 (de) 2011-03-24

Family

ID=36097233

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026310T Expired - Lifetime DE602005026310D1 (de) 2004-10-29 2005-10-25 Verfahren zur herstellung von ibandronat

Country Status (13)

Country Link
US (1) US7214818B2 (https=)
EP (1) EP1807090B9 (https=)
JP (1) JP4560548B2 (https=)
KR (1) KR100880061B1 (https=)
CN (1) CN101048165B (https=)
AT (1) ATE497769T1 (https=)
CA (1) CA2585027C (https=)
DE (1) DE602005026310D1 (https=)
ES (1) ES2359415T3 (https=)
IL (1) IL182690A (https=)
MX (1) MX2007005114A (https=)
TW (1) TWI293304B (https=)
WO (1) WO2006045578A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000087A (es) * 2004-06-23 2007-11-06 Teva Pharma Acido ibandronico solido y cristalino.
WO2007074475A2 (en) * 2005-12-27 2007-07-05 Natco Pharma Limited Novel polymorphic forms of ibandronate
US8178712B2 (en) 2006-06-23 2012-05-15 Cipla Ltd. Process for the synthesis of Ibandronate sodium
WO2008004000A1 (en) * 2006-07-03 2008-01-10 Generics [Uk] Limited Novel process for the preparation of bisphosphonic acids
WO2008014510A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Limited Crystalline form a of ibandronic acid and process for the preparation
EP2009016A3 (en) * 2006-11-16 2009-02-25 Teva Pharmaceutical Industries Ltd Process for preparing crystalline form of ibandronate sodium
CA2570949A1 (en) * 2006-12-12 2008-06-12 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
BRPI0809548A8 (pt) 2007-04-11 2018-10-16 Hoffmann La Roche processo para a preparação do sal ácido- (mono-hidratado)-3- (n-metil-n-pentil) amino-1-hidroxipropano-1, 1-difosfônico monossódico
AU2008242788A1 (en) * 2007-04-19 2008-10-30 Dr. Reddy's Laboratories Ltd. Ibandronate sodium polymorphs
WO2009020483A1 (en) * 2007-08-09 2009-02-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of ibandronate sodium
US20090075944A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched ibandronate
WO2009093258A2 (en) * 2008-01-24 2009-07-30 Fleming Laboratories Limited A new and improved process for the preparation of ibandronate sodium monohydrate
EP2180003A1 (en) 2008-10-21 2010-04-28 Zentiva, k.s. Preparation of ibandronate trisodium
EP2192126B1 (en) 2008-11-26 2013-03-27 Synthon B.V. Process for making zoledronic acid
US20100130746A1 (en) * 2008-11-26 2010-05-27 Martin Kas Process for Making Zoledronic Acid
CN101863919B (zh) * 2010-07-05 2011-11-23 武汉同源药业有限公司 一种化合物伊班膦酸钠的制备方法
CN102093416B (zh) * 2011-03-17 2013-07-24 南京恒生制药有限公司 一种合成伊班膦酸钠的方法
CN103012155A (zh) * 2012-11-29 2013-04-03 张家港市大伟助剂有限公司 一种n-甲基戊胺的制备方法
CN103396332A (zh) * 2013-08-19 2013-11-20 四川协力制药有限公司 3—[（n—甲基—n—戊基）氨基]丙酸盐酸盐的制备方法
CN104628768A (zh) * 2015-03-06 2015-05-20 江苏正大清江制药有限公司 一种伊班膦酸钠的制备方法
CN114524925B (zh) * 2020-11-23 2023-11-14 华润化学材料科技股份有限公司 钛系催化剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919321A (en) * 1966-11-08 1975-11-11 Hoffmann La Roche Halo-substituted-5H-dibenzo{8 a,d{9 cyclohepten-5-ones
US4220611A (en) 1978-06-29 1980-09-02 Sandoz, Inc. Polyoxyalkylene bridged phosphate esters
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3808074A1 (de) 1988-03-11 1989-09-21 Henkel Kgaa Verfahren zur herstellung von azacycloalkan-2,2-diphosphonsaeuren
DE3822650A1 (de) 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4922007A (en) 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
KR100681282B1 (ko) 2002-05-17 2007-02-12 테바 파마슈티컬 인더스트리즈 리미티드 특정 희석제를 사용하는 비스포스폰산 및 그 염의 제조방법

Also Published As

Publication number Publication date
KR100880061B1 (ko) 2009-01-22
WO2006045578A3 (en) 2006-08-17
IL182690A0 (en) 2007-09-20
JP2008517964A (ja) 2008-05-29
EP1807090B9 (en) 2011-11-09
JP4560548B2 (ja) 2010-10-13
WO2006045578A2 (en) 2006-05-04
MX2007005114A (es) 2007-06-26
EP1807090B1 (en) 2011-02-09
ES2359415T3 (es) 2011-05-23
TWI293304B (en) 2008-02-11
EP1807090A2 (en) 2007-07-18
IL182690A (en) 2011-07-31
ATE497769T1 (de) 2011-02-15
CA2585027A1 (en) 2006-05-04
US7214818B2 (en) 2007-05-08
CN101048165B (zh) 2010-12-01
CA2585027C (en) 2010-05-18
TW200621792A (en) 2006-07-01
CN101048165A (zh) 2007-10-03
US20060094898A1 (en) 2006-05-04
KR20070070246A (ko) 2007-07-03

Similar Documents

Publication Publication Date Title
DE602005026310D1 (de) Verfahren zur herstellung von ibandronat
NO20073723L (no) Ibandronatpolymorf A
NO20073755L (no) Ibandronatpolymorf B
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
TW200801027A (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
ATE552230T1 (de) Verfahren zur herstellung von derivaten aus 1-(2- halobiphenyl-4-yl)-cyclopropancarboxylsäure
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
EA201170057A1 (ru) Способ получения замещенных 2-аминотиазолонов
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
MX2009010850A (es) Sintesis de ibandronato en multiples etapas.
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE519765T1 (de) Verfahren zur herstellung von 3-hydroxymorphinan- derivaten
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan
ATE546458T1 (de) Verfahren zur herstellung von 6-alpha, 9-alpha-
DE602005025140D1 (de) Verfahren zur herstellung von alkylphosphinaten
BR112012012908A2 (pt) processo de preparo de um derivado de combretastatina
WO2012070896A3 (en) Synthetic method of enantiomerically pure 2,2'-dihydroxy-1,1'-binaphthyl-3-carboxylic acid
SE0402462D0 (sv) New process
DE602006020760D1 (de) Verfahren zur herstellung von perindoprilerbumin
DE602007007773D1 (de) Verfahren zur synthese von ibandronat-natrium
ATE381532T1 (de) Verfahren zur herstellung von gabapentin